NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Publication Year 2019 Remove constraint Publication Year: 2019

Search Results

304. Oncology therapeutic radiopharmaceuticals: nonclinical studies and labeling recommendations

306. Osteoporosis: nonclinical evaluation of drugs intended for treatment

307. Placebos and blinding in randomized controlled cancer clinical trials for drug and biological products

308. Factors to consider when making benefit-risk determinations in medical device premarket approval and de novo classifications: guidance for industry and Food and Drug Administration staff

309. Consideration of uncertainty in making benefit-risk determinations in medical device premarket approvals, de novo classifications, and humanitarian device exemptions: guidance for industry and Food and Drug Administration staff

310. Evaluation of internal standard responses during chromatographic bioanalysis: questions and answers